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SUMMARY
Bisphenol A is widely used in food contact materials and other products and is detected in human urine and blood. Bisphenol A
may affect reproductive and neurological development; however, opinion of the European Food Safety Authority (EFSA) on bisphe-
nol A (EFSA J, 13, 2015 and 3978) concluded that none of the available studies were robust enough to provide a point of departure for
setting a tolerable daily intake for bisphenol A. In the present study, pregnant Wistar rats (n = 17–21) were gavaged from gestation
day 7 to pup day 22 with bisphenol A doses of 0, 25 lg, 250 lg, 5 mg or 50 mg/kg bw/day. In the offspring, growth, sexual matura-
tion, weights and histopathology of reproductive organs, oestrus cyclicity and sperm counts were assessed. Neurobehavioural devel-
opment was investigated using a behavioural testing battery including tests for motor activity, sweet preference, anxiety and spatial
learning. Decreased sperm count was found at the lowest bisphenol A dose, that is 25 lg/kg/day, but not at the higher doses. Repro-
ductive organ weight and histology were not affected and no behavioural effects were seen in male offspring. In the female offspring,
exposure to 25 lg/kg bw/day bisphenol A dose resulted in increased body weight late in life and altered spatial learning in a Morris
water maze, indicating masculinization of the brain. Decreased intake of sweetened water was seen in females from the highest
bisphenol A dose group, also a possible sign of masculinization. The other investigated endpoints were not significantly affected. In
conclusion, the present study using a robust experimental study design, has shown that developmental exposure to 25 lg/kg bw/day
bisphenol A can cause adverse effects on fertility (decreased sperm count), neurodevelopment (masculinization of spatial learning in
females) and lead to increased female body weight late in life. These results suggest that the new EFSA temporary tolerable daily
intake of 4 lg/kg bw/day is not sufficiently protective with regard to endocrine disrupting effects of bisphenol A in humans.
INTRODUCTION
Bisphenol A (BPA) is a high production volume chemical used
mainly as a monomer in the manufacturing of numerous chemi-
cal products, including polycarbonate plastics and epoxy resins.
BPA is present in many products, and consumer exposure may
arise from migration of BPA from polycarbonate or epoxy-lined
food and drink containers, from dental sealants, from microwave
containers into food during heating (Salian et al., 2011) or from
thermal and recycled paper (Vinggaard et al., 2000; Liao & Kan-
nan, 2011).
The toxicity of BPA has been extensively investigated by indus-
trial, governmental and academic research groups in several
reproductive toxicity and multi-generational exposure studies.
Health concerns regarding human exposures to BPA have in the
past arisen from its well-known estrogenic properties (Salian
et al., 2011). BPA has affinity for nuclear oestrogen receptors
(ERa and ERb) and estrogenic activity in vivo giving rise to
increased uterine wet weights in the uterotrophic assay (Sik Kim
et al., 2005). Furthermore, BPA exposure during development
has been shown to affect semen quality (vom Saal et al., 1998;
Salian et al., 2009), alter prostate weights (vom Saal et al., 1998;
Timms et al., 2005; Prins & Korach, 2008) and increase the inci-
dence of PIN lesions in the prostate of adult rodents (Prins et al.,
2011). Moreover, low-dose effects have been observed for a wide
range of endpoints. In rodent studies, adverse effects of BPA
doses at or below 250 lg/kg bw/day have been reported for
reproductive organ weights (Ashby et al., 1999; Chitra et al.,
2003), mammary gland development (Munoz-de-Toro et al.,
2005) and behaviour, for example anxious behaviour and
impaired learning (Della Seta et al., 2005; Ryan & Vandenbergh,
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2006; Gioiosa et al., 2007; Goncalves et al., 2010; Xu et al., 2010,
2011a; Ayyanan et al., 2011; Jasarevic et al., 2013). The majority
of these low-dose effects have been observed after exposure dur-
ing the developmental period when both the reproductive sys-
tem and the brain are most susceptible to endocrine
disturbances. The European Food Safety Authority (EFSA) have
concluded in their opinion on bisphenol A (BPA) in January 2015
that none of the available studies showing effects at low doses
were robust enough to provide a point of departure for setting a
Tolerable Daily Intake (TDI) for BPA.
The aim of the present study was to investigate reproductive
development in male and female Wistar rats after perinatal
exposure to BPA using a sufficient number of litters per group
and low doses in the lg/kg dose range (25 and 250 lg/kg bw/
day) as well as dose levels similar to those that formed the basis
for establishment of the earlier TDI from EFSA.
From this study we have earlier reported decreased anogenital
distance (AGD) in the newborn male and female offspring from
dose levels of 250 and 25 lg/kg bw/day, respectively, indicating
endocrine disrupting effects on reproductive development at low
doses of BPA (Christiansen et al., 2014). Also, effects of BPA on
mammary gland development at 25 and 250 lg/kg are reported
in Mandrup et al. (2016). The present study reports the results
with regard to effects of BPA on sexual maturation, weights and
histopathology of reproductive organs, oestrus cyclicity and
sperm counts as well as sexually dimorphic behaviour.
MATERIALS ANDMETHODS
Chemicals
Bisphenol A (purity >99.5%, CAS no. 80-05-7) was purchased
from Sigma-Aldrich (Brøndby, Denmark). Corn oil used both as
negative control and as vehicle was purchased from Sigma-
Aldrich. The corn oil was provided to the laboratory in glass bot-
tles. The dosing solutions were kept in glass bottles in the dark,
at room temperature and continuously stirred during the dosing
period. The levels of BPA in the solutions were verified by chemi-
cal analysis.
Animals and treatment
The animal study was carried out at the DTU National Food
Institute facilities. Ethical approval was given by the Danish Animal
Experiments Inspectorate (Council for Animal Experimentation).
The authorization number given was 2012-15-2934-00089 C4. The
experiments were overseen by the National Food Institutes in-
house Animal Welfare Committee for Animal Care and Use.
A total of 110 time-mated nulliparous, young adult Wistar rats
(HanTac:WH, SPF, Taconic Europe, Ejby, Denmark) were sup-
plied at gestation day (GD) 3 of pregnancy. The day when a vagi-
nal plug was detectable was designated as gestation day (GD) 1
and the expected day of delivery, GD 23, was designated as pup
day (PD) 1. The study was performed in three blocks (separated
by 1 week), and all dose groups were equally represented in
these blocks. The dams were given 4 days after arrival to adapt
to the reversed light–dark cycle before beginning the exposure.
The animals were housed in pairs until GD 17 and alone there-
after under standard conditions in semi-transparent polysulfone
cages, as described in detail in Christiansen et al. (2014). The
polysulfone bottles and cages, as well as the aspen wood shelters
(instead of polycarbonate), were used to reduce the risk of
migration of BPA that potentially could confound the study
results.
The day after arrival (GD 4), time-mated dams were dis-
tributed into five groups of 22 rats with similar body weight (bw)
distributions. The dams received vehicle (controls) or the follow-
ing doses of BPA: 25 lg, 250 lg, 5 mg or 50 mg//kg bw/day. Test
compounds and vehicle were administered by oral gavage with a
stainless steel probe 1.2 9 80 mm (Scanbur, Karlslunde, Den-
mark) once daily in the morning from GD 7 to the day before
expected birth (GD 21) and again after birth from PD 1 to 22 at a
constant volume of 2 mL/kg bw/day. Dams that did not give
birth were omitted from the study. The exposure period was
chosen to cover the most sensitive periods of the development
of the reproductive system in the offspring, that is beginning
after the time of implantation and continuing throughout the
lactation period. Throughout the study only dams were gavaged,
meaning that offspring exposure was indirect, first through pla-
cental transfer and hereafter through the milk. The individual
doses were based on the body weight of the dams on the day of
dosing. The dams were inspected twice a day for general toxicity
including changes in clinical appearance. Body weights were
recorded on GD 4 and daily during the dosing period to monitor
changes in weight gain, to follow pregnancy status and to adjust
dose according to weight. The number of live-born litters in the
five dose groups, respectively, was 17, 19, 15, 16 and 16. Details
regarding pre- and early postnatal development are presented in
Christiansen et al. (2014).
On PD 22, two male and two female pups per litter were
weaned. One subset of animals (one male and one female from
each litter) was terminated around 3 months of age (PD 105–
116) and sperm count and reproductive organ weight were
assessed. The other subset was used for behavioural studies,
assessment of oestrus cyclicity and was terminated around
9 months for the males and 14 months for the females.
Section of dams and offspring PD 22
The male and female pups which were not to be kept after
weaning were decapitated on PD 22 in CO2/O2 anaesthesia.
Testes and ventral prostate from one male pup per litter and
ovaries from one female per litter were dissected and weighed.
Testes were fixed in Bouin’s fixative and ventral prostate were
fixed in formalin and embedded in paraffin. Dams were decapi-
tated in CO2/O2 anaesthesia and the number of uterine implan-
tations was counted.
Onset of puberty
Onset of puberty was registered in all weaned male and female
offspring. In female offspring sexual maturity was assessed by
determining day of vaginal opening (VO) and the females were
examined daily from PD 25 until all were positive. In male off-
spring the onset of puberty was assessed as time of preputial
separation (PPS). Males were examined daily from PD 38 until
all were positive. On the day of VO or PPS the age and weight of
the animals were recorded.
Oestrus cyclicity
Vaginal smears were collected every morning for 21 consecu-
tive days, starting when the female offspring were around
12 months old. The smear samples were air-dried, fixed in etha-
nol, stained, and examined by light microscopy by an
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investigator blinded to the exposure groups. Stages were recog-
nized in terms of the presence, absence, or proportional num-
bers of epithelial cells and cornified cells and were classified as
oestrus or not oestrous. The animals were categorized as either
being regularly cycling (cycles lasting 4–5 days), or as being
irregularly cycling which was defined as having cycles lasting
less than 4 days or more than 5 days. Furthermore, episodes of
3–4 consecutive days of vaginal oestrus and 5 days or more
between vaginal oestrous were considered extended.
Section of 3–4 months old offspring (males: PD 97–107, females:
PD 110–125)
The adult pups were weighed and decapitated in CO2/O2
anaesthesia. Vaginal smears were performed on females in the
morning, and females in proestous or oestrous were selected for
autopsy over a 2-week period. Ovaries, retroperitoneal fat pads,
livers and thyroid glands were dissected from females and
weighed.
Male reproductive organs were examined macroscopically for
anomalies. Testis, epididymis, ventral prostate, seminal vesicle,
levator ani/bulbocavernosus muscle (LABC), bulbourethral
gland, retroperitoneal fat pads and liver were dissected from one
male pup per litter and weighed. Ventral prostates were fixed in
formalin and embedded in paraffin.
Section of 8 months old male offspring
The adult males were weighed and decapitated in CO2/O2
anaesthesia. Testis, ventral prostate, seminal vesicle (weighed
with ventral and dorsolateral prostate), epididymis, levator ani/
bulbocavernosus muscle (LABC), bulbourethral glands and liver
were excised and weighed. Testes were fixed in Bouin’s fixative,
and ventral prostates were fixed in formalin and embedded in
paraffin.
Section of 14 months old female offspring
Vaginal smears were performed on females in the morning,
and females in proestous or oestrous were selected for autopsy
over a 1-week period. A few females were not cycling and were
sacrificed at the end of the study period. Females were weighed
and decapitated in CO2/O2 anaesthesia. Ovaries, pituitary gland,
liver and retroperitoneal fat pad were excised and weighed, and
ovaries were fixed in formalin and embedded in paraffin.
Histopathology and morphometry
At PD 22, one section per testis and ventral prostate from the
control group, the lowest dose group and the highest dose group
were stained with haematoxylin and eosin (H&E). Immunohisto-
chemical staining for the proliferation marker Ki67 was per-
formed on one ventral prostate section for all males from the
control group, the lowest dose group and the highest dose group
as described by Boberg et al. (2015). Quantification of Ki67-posi-
tive epithelial cells, calculation of proliferation index and
morphometrical analyses of lumen:epithelium ratios and distri-
bution of compartments of the ventral prostate were performed
as described in Boberg et al. (2015). In testes, lumen formation
and seminiferous tubular diameter was examined in four ran-
domly selected fields per section at 109magnification.
At 3 and 8 months of age, histological examination was per-
formed on one H&E stained section per ventral prostate and one
H&E stained section per testis from the control group and the
low-dose group. In testes from 3 months old males, seminifer-
ous tubular diameter was examined in four randomly selected
fields per section at 109magnification.
Ventral prostates were scored according to Isling et al. (2014)
for presence of epithelial atrophy, epithelial cell height, intersti-
tial inflammation, epithelial atypical hyperplasia, presence of
cribriform patterns in areas of hyperplasia and luminal concre-
tion. Testes were evaluated for spermatid retention, tubular dila-
tion, degeneration of germ cells and Leydig cell hyperplasia.
Ovaries from 4 months old offspring were examined for pres-
ence of corpora lutea to evaluate reproductive senescence.
Sperm count
For sperm count analysis, samples were analysed using com-
puter-assisted sperm analysis (CASA). From 3 months old male
offspring, alternately left or right cauda epididymis including
1 cm of ductus deferens was frozen in liquid nitrogen and stored
at 80 °C for sperm count analysis. The cauda epididymis was
thawed, weighed and prepared as described by Jarfelt et al.
(2005), and samples were analysed using a 109 UV fluorescent
objective and IDENT OPTIONS on the CASA. Ten fields were
analysed for each sample and three counts were performed for
each suspension. Counts were averaged and data are presented
as number of spermatozoa per gram cauda.
Behavioural testing
The behavioural testing was performed during the animals’
dark cycle, that is their active period, from 9 AM to 4 PM, in dimly
lit rooms. There were one male and one female from each litter
and 18–22 litters per group. The experimenter was unaware as to
which group an individual rat belonged and exposed and control
animals were tested alternately.
Elevated plus maze. The animals were tested at the age of 3–
4 months (PND 90–112) in an elevated plus maze. This maze
was made of grey PVC and consisted of two open arms,
50 9 10 cm, and two opposite enclosed arms, 50 9 10 9 40 cm,
with an open roof. Metal ledges (1 cm) were made along the
edges of the open arms to minimize the risk of falling down dur-
ing testing. The enclosed arms were closed at the end opposite
to the centre. The centre of the maze was represented by an area
10 9 10 cm, thus the maze formed the shape of a plus sign. It
was elevated to a height of 50 cm above the floor. An infra red
camera was mounted vertically above the central square
recorded the rat behaviour in dark. All the test animals were ini-
tially placed in the centre of the plus maze facing the same direc-
tion towards one of the open arms. The experimenter left the
room just after placing the rat. The maze was cleaned with etha-
nol following each trial. The behaviour was scored by an obser-
ver blind to the treatment using a manual software timer with
split time function. Scored parameters included time spent in
open/close/centre and number of entries to each of the arms as
well as latencies to each arm in the maze. The entries of an arm
were registered when the animal entered an area with both front
paws.
Learning and memory (Morris water maze). The animals were
tested at the age of 4–6 months in a maze with a diameter of
220 cm, filled with water at room temperature, as described ear-
lier (Hass et al. 1995, 1999; Axelstad et al., 2008). A circular
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transparent platform was situated on a solid support and sub-
merged below the water surface. When the rat swam to and
climbed onto the platform, the trial was completed. If the animal
failed to locate the platform within 60 sec, it was led to the plat-
form. A video-tracking device (ViewPoint VideoTrack System,
Sandown Scientific, Middlesex, UK) was used to collect data
about latencies to find the platform, the path lengths and swim-
ming speeds of the animals.
Learning was tested with the platform situated at the centre of
the south west quadrant of the pool, and the animals were tested
in four trials per day for 8 days (five consecutive days, 2 days
break and then three more days).
Motor activity and habituation. The animals were tested 2 days
after the last day of Morris water testing at the age of 4–
6 months. The motor activity of the animals was recorded in
activity boxes with photocells for 10 9 3 min (as described in
Axelstad et al., 2008). The total activity during the 30 min was
used as a measure of general activity. In order to assess habitua-
tion capability, the activity within the 30 min was also divided
into two time periods of 15 min and analysed separately.
The sweet preference test. At the age of 6–7 months, the offspring
were tested in the sweet preference test. One week prior to the
test, the rats were housed individually, their weight was recorded
and each rat was given two water bottles with acidified tap water
to acclimatize to more than one bottle to choose from. During
the saccharin preference test, each rat was provided with one
bottle containing deionized tap water, while the other bottle
contained a 0.1% saccharin solution dissolved in acidified tap
water. The saccharin bottles were placed alternately right and
left in relation to water bottles, to avoid position preference. The
consumption of water and saccharin solution was recorded daily
at 10:00 AM for 4 days and bottles were refilled when needed. At
the fifth and last test day bottles were weighed and the rats were
rehoused in pairs and only given one water bottle.
The saccharin preference score was calculated as the relative
saccharin intake [intake of saccharin water (g) per 100 g bw] and
as the absolute saccharin intake (with bw was used as a covariate
in the statistical analysis). All rats maintained ad libitum soy-free
Altromin diet throughout the behavioural test.
Statistical analysis
For all analyses, the level of significance was set at 0.05. Data
with normal distribution and homogeneity of variance were
analysed using analysis of variance (ANOVA). For analysis of organ
weights, ANCOVA, using body weight as a covariate, was used. For
body weights of the adult offspring, repeated measures analysis
were used. When more than one pup from each litter was exam-
ined, statistical analyses investigating the effect of litter were
performed. When appropriate, the model was adjusted using lit-
ter as an independent, random and nested factor in ANOVA,
whereas the data were analysed without the nested design, when
this resulted in the best fitted model. Where an overall signifi-
cant treatment effect was observed, two-tailed comparison was
performed using least square means or Dunnett’s post hoc test.
Testing for non-monotonic dose–response relationships was
performed using a Tukey’s test for LSMeans Dichotomous histo-
logical data were evaluated using the 2 9 2 Fisher’s exact test.
All statistical analyses were performed using (SAS Enterprise
Guide 4.3 Statistical Software (SAS Institute, Inc., Cary, NC,
USA)).
RESULTS
Reproductive development and body weights
Body weights of male pups were not altered by the BPA expo-
sure at any age (Table 1). Female pup body weights were similar
among groups until the age of approximately 6 months, but
were significantly increased compared to controls in the 25 lg/
kg dose group at 9–13 months of age, and at the final sacrifice
(Fig. 1, repeated measures analysis, p = 0.025).
On PD 22, weights of the testes, ovaries and ventral prostate
were unaffected by BPA exposure (Table 1). BPA exposure did
not affect lumen formation or seminiferous tubule diameters in
testes, proliferation index of prostate epithelium or the morpho-
metric parameters analysed in ventral prostates at PD 22 (data
not shown).
In 3 months old males, significantly decreased sperm count
was seen at the lowest tested BPA dose of 25 lg/kg bw/day,
(p = 0.0373), but not at the higher doses (Fig. 2). The effect was
only statistically significant when an outlier in the 50 mg/kg bw/
day dose group was excluded from the analysis. This one male
showed a sperm count that was approximately 10 times lower
than seen in the rest of the males, and the seminal vesicles of
this male were small and underdeveloped. This effect was judged
not to be a treatment-related effect, since such malformations
have previously also been seen in control males in our laboratory
(Axelstad et al., 2011; Isling et al., 2014). Thus, because of the
observed malformations, the sperm count data from this one
male were excluded from the analysis, as they were not consid-
ered representative.
Sperm count in the males from the 25 lg/kg bw/day group
were also significantly lower than sperm count in males in the
50 mg/kg bw group, indicating a non-monotonic dose–response
relationship.
Ventral prostate weight appeared increased at 25 lg/kg bw/
day, but the increase was not statistically significant compared
to controls (p = 0.08). No changes in weight of testes, epi-
didymides, bulbourethral glands, LABC, liver, retroperitoneal fat
pad or body weight were seen in the 90-day-old offspring
(Table 1). Overall, histological examination of testes and mea-
surement of tubule diameter showed no significant differences
between controls and males from the 25 lg/kg bw/day group
(data not shown). In one testis from the low-dose group, an area
of dysgenetic tubules with impaired spermatogenesis was seen
inside a Leydig cell cluster, and another animal from the low-
dose group had spermatid retention and multinucleated sper-
matid aggregates (as described in Creasy, 2001) in a few tubules
scattered throughout the testis. As these findings were only seen
in two of 22 examined testes from the low-dose group, this was
not considered to be clearly related to BPA exposure.
In 4 months old female offspring, no changes in weights of
ovaries (right and left combined), liver, thyroids or retroperi-
toneal fat pad were observed.
Organ weights and histological examination in 8 months old
male offspring and 14 months old female offspring
At 8 months of age, the prostate and seminal vesicle were dis-
sected and weighed together and showed an increased weight at
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5 mg BPA/kg compared to controls (p = 0.013, Table 1). No
changes were seen in weights of testis, ventral prostate, epi-
didymides, bulbourethral glands, LABC, liver or body weight at
8 months of age (Table 1). In the 14 months old female off-
spring, no changes were observed in the weights of ovaries (right
and left combined), liver, pituitary gland or retroperitoneal fat
pad.
Histological examination of ventral prostates revealed a higher
prevalence of interstitial inflammation at 3 months than at
8 months of age, and an increased incidence of epithelial atro-
phy with increasing age. No differences between controls and
low-dose males were seen for these or other endpoints examined
in ventral prostates. In testes, one male from the low-dose group
showed degeneration of seminiferous tubules, but no differences
between dose groups were observed. In ovaries, 2–3 females per
dose group had no corpora lutea (CL), whereas 1–3 females per
dose group had 1–3 CL in the evaluated ovary section, indicating
no or impaired oestrous cyclicity. There were no statistically dif-
ferences between dose groups for these observations or in the
mean number of CL (data not shown).
Onset of puberty
No effects of BPA were found with regard to the time for sexual
maturation of male offspring or the body weight at puberty onset
(data not shown). The puberty onset in the BPA-exposed female
offspring appeared to be 0.5–1.2 days earlier in all exposed
groups, but no significant differences were found (data not
shown).
Oestrus cyclicity
The results of the scoring of the vaginal smears taken for eval-
uation of oestrus cyclicity at 1 year of age showed as expected
Table 1 Organ weights. Effect of BPA on body weights (BW) and weight of reproductive organs
Control 25 lg/kg 250 lg/kg 5 mg/kg 50 mg/kg
Male, PND 22
N 17 19 14 14 16
Body weight (g) 44.1  4.2 45.1  4.1 41.1  4.7 42.7  3.5 43.8  6.8
Right testis (mg) 116  11 119  13 108  13 110  9 115  19
Left testis (mg) 118  13 121  12 111  12 112  8 115  20
Prostate (mg) 29.8  4.4 32.7  4.8 29.9  5.8 31.3  2.8 30.1  5.3
Female, PND 22
N 14 17 15 16 14
Body weight (g) 40.9  5.0 43.3  4.3 41.4  4.8 43.6  4.6 41.3  6.2
Right ovary (mg) 7.71  1.39 8.22  1.36 7.67  1.45 8.05  1.97 7.71  1.84
Left ovary (mg) 7.81  1.72 8.34  1.14 8.09  1.48 8.65  1.22 7.87  1.61
Male, 3 months
N 20 22 17 19 18
Body weight (g) 352  40 365  30 334  30 341  32 340  34
Right testis (g) 1.76  0.10 1.79  0.15 1.73  0.11 1.76  0.13 1.75  0.13
Left testis (g) 1.80  0.11 1.81  0.15 1.76  0.11 1.80  0.15 1.82  0.14
Prostate (g) 0.45  0.08 0.51  0.07 0.48  0.07 0.44  0.07 0.48  0.09
Epididymis (g) 0.56  0.06 0.56  0.05 0.54  0.02 0.55  0.02 0.54  0.05
Seminal vesicle (g) 1.32  0.18 1.40  0.22 1.40  0.13 1.40  0.20 1.26  0.18
LABC (g) 0.96  0.14 0.99  0.11 0.93  0.09 0.96  0.10 0.94  0.12
Bulbourethral gland (g) 0.103  0.021 0.107  0.029 0.103  0.019 0.105  0.031 0.102  0.029
Liver (g) 10.72  1.53 11.67  1.59 10.19  1.04 10.31  1.07 10.47  1.32
Retroperitoneal fat pad (g) 1.37  0.54 1.74  0.50 1.48  0.50 1.39  0.41 1.42  0.45
Female, 4 months
N 21 20 17–18 17–19 15
Body weight (g) 213  14 218  12 208  15 214  17 218  36
Ovaries (mg) 83.6  16.4 87.4  15.8 83.9  11.8 83.1  12.3 89.4  16.1
Retroperitoneal fat (mg) 717  172 747  240 670  193 641  175 727  196
Liver (g) 6.35  0.98 6.49  0.56 6.18  0.65 6.45  0.77 6.45  0.79
Thyreoidea (mg) 15.6  6.2 14.7  2.0 13.6  2.2 15.7  5.9 15.0  3.4
Male, 8 months
N 20 22 18 20 18
Body weight (g) 461  49 476  44 464  46 462  37 463  39
Right testis (g) 1.98  0.16 1.88  0.14 1.89  0.16 1.89  0.15 1.92  0.21
Left test (g) 1.98  0.15 1.91  0.14 1.95  0.16 1.95  0.17 1.93  0.16
Prostate/seminal vesicle (g) 2.96  0.44 3.05  0.46 3.08  0.30 3.38  0.50* 3.02  0.37
Ventral prostate (g) 0.71  0.14 0.75  0.16 0.76  0.15 0.76  0.14 0.70  0.13
Liver (g) 12.4  1.7 13.0  1.7 12.4  1.7 12.4  1.4 12.6  1.5
Epididymis (g) 1.32  0.17 1.30  0.10 1.31  0.10 1.39  0.17 1.29  0.19
Bulbourethral gland (g) 0.198  0.062 0.205  0.059 0.220  0.058 0.212  0.070 0.176  0.071
LABC (g) 1.30  0.14 1.30  0.18 1.27  0.12 1.36  0.15 1.31  0.16
Female, 14 months
N 20 21 18 19 18
Body weight (g) 280  25 304  35 291  27 282  31 277  28
Ovaries (mg) 72.8  21.3 85.9  23.9 83.7  24.0 79.1  28.8 75.5  21.5
Pituitary (mg) 17.7  4.7 18.3  7.1 16.8  2.19 17.8  4.0 15.3  2.7
Liver (g) 7.47  0.78 7.73  1.34 7.57  1.16 7.46  1.29 7.09  0.92
Retroperitoneal fat pad (g) 2.00  0.82 2.31  0.74 2.08  0.63 1.97  0.77 2.22  1.01
*p < 0.05 compared to control. Data represent group means  SD. BW was used as a covariate in the statistical analyses. All significant results are written in bold.
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based on our previous study (Isling et al., 2014) that only around
60% of the control animals were still regularly cycling (Fig. 3).
Somewhat lower frequencies ranging from 32 to 44% were seen
in the BPA-dosed animals. Statistical analysis showed, however,
that none of the dosed groups were significantly different from
the control group (ps = 0.11 or higher).
Behavioural effects
Anxiety in elevated plus maze
Results from the elevated plus maze test showed that in both
male and female offspring this behaviour was not significantly
affected by BPA exposure in any of the tested dose groups (data
not shown). Large variations in the data were seen. Moreover,
the expected sex difference in control rats with female rats being
significantly more in the open arms than control males was not
found.
Spatial learning in the Morris water maze
Over the 8-day testing period, the expected sex difference in
control rats was seen (p < 0.01) with male rats swimming a
shorter distance before reaching the platform (p = 0.001,
Fig. 4A). The control males also found the platform faster (i.e.
had shorter latencies) (p = 0.004) (Fig. 4C) compared to control
females, although they swam significantly slower than the con-
trol females (p = 0.003) (Fig. 4B).
In the female offspring, exposure to the low dose of BPA
(25 lg/kg) caused significantly shorter swim lengths (p = 0.024)
(Fig. 4A) and significantly slower swim speeds (p = 0.0045)
(Fig. 4B) than in control females, making the behaviour of these
low-dose BPA-exposed females resemble the male maze
performance.
With regard to swim length, the female offspring from the low
dose of BPA group (25 lg/kg) were not significantly different
from the two next dose groups (i.e. 250 lg/kg and 5 mg/kg)
(Fig. 4A), but their swim lengths were significantly shorter than
in the 50 mg/kg group (p = 0.011), indicating a non-monotonic
dose–response relationship. Swim speed in the females from the
25 lg/kg group were not only significantly different from control
females but also from females in the 5 and 50 mg/kg bw groups
(p = 0.028 and 0.0036 respectively), again indicating a non-
monotonic dose–response relationship.
BPA exposure did not significantly affect female latency to
reach the platform, and did not significantly affect maze perfor-
mance in the male offspring.
As described earlier, significant sex differences were seen in
the control group for all three measured endpoints, that is
swim length, swim speed and latency. This was not the case
for the animals from the 25 lg/kg group, where there was no
significant sex difference in any of these three measurements
(p = 0.18, p = 0.80 & p = 0.068 respectively), corroborating
that the performance of the females in this dose group
resembled that of males. A significant difference between the
sexes, similar to the one seen in the control animals, was
seen in the groups exposed to 250 lg/kg (p = 0.0018,
p = 0.022, p = 0.004) and 50 mg/kg (p = 0.0003 p = 0.0008 &
Figure 1 Body weights in female rats exposed to 0, 25 lg, 250 lg, 5 mg
or 50 mg BPA/kg bw/day from GD 7 to PD 22. Group mean values  SEM
are shown, n = 17–22. *p < 0.05 in the 25 lg/kg group compared to the
control group.
Figure 2 Number of spermatozoa per gram cauda epididymis in 3 months
old male rats exposed to 0, 25 lg, 250 lg, 5 mg or 50 mg BPA/kg bw/day
from GD 7 to PD 22. Group mean values  SEM are shown, n = 17–22.
Sperm count is significantly lower, indicated by * with p < 0.05, in the
25 lg/kg group compared to the control group, when an outlier in the
highest dose group (50 mg/kg) is excluded from the statistical analysis (see
text for details). # represents a statistical significant difference from the
50 mg/kg group (p < 0.05).
Figure 3 The percentage of females with regular oestrus cyclicity at
approximately 1 year of age, female offspring exposed perinatally to 25 lg,
250 lg, 5 mg or 50 mg BPA/kg bw/day. Lower frequencies ranging from
32 to 44% were seen in the BPA-dosed animals compared to 60% in the
control, but no statistically significant differences from controls were
observed (ps = 0.11 or higher).
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p = 0.0002), but was missing for all three endpoints in the
group exposed to 5 mg/kg bw/day (p = 12.9, p = 11.8 &
p = 13.7).
Motor activity levels in male and female offspring were not
affected in any dose groups (data not shown).
Sweet preference test
The expected gender difference in saccharin consumption
between male and female offspring with females consuming
more sweet water than males was seen, when analysing the rela-
tive intake of sweet water (mL intake of saccharin solution per
100 g of body weight) (p < 0.01). In adult female offspring, a
decreased intake of saccharin water was seen with increasing
BPA exposure, with a statistically significant downwards trend
(p < 0.025) and females from the highest dose group showed sig-
nificantly decreased intake of sweetened water compared to
controls (p < 0.05) (Fig. 5). BPA exposure had no effect on sweet
preference in male offspring (data not shown),
DISCUSSION
In the present study, the developmental BPA exposure caused
reproductive toxicity effects manifested as decreased sperm
count. Also, female body weight was increased during the last
part of the study, that is at 9–14 months of age. No clear signs of
effects on male behaviour were found, however, spatial learning
of the females was affected. These effects were all found after
exposure to the lowest dose of BPA, that is 25 lg/kg, but not at
higher doses.
Sperm count
The decreased sperm count at the lowest tested BPA group
(25 lg/kg) is to some extent supported by other studies report-
ing decreased sperm count in rodents after low-dose develop-
mental exposure to BPA (Vom et al., 1998; Salian et al., 2009).
Salian et al. (2009) performed a three-generation study to assess
the effects of very low doses of BPA (1.2 or 2.4 lg/kg bw/day
administered by gavage) in Holtzman rats (n = 8 litters per
group/generation). Sperm count and motility were significantly
reduced in the F1, F2 and F3 male offspring, with a dose-related
reduction in sperm count. In Vom et al. (1998), pregnant CF-1
mice (n = 5 per group) were fed with 2 and 20 lg BPA/kg bw
from GD 11–17. The daily sperm production was impaired in the
group exposed to 20 lg/kg BPA, that is at a dose level that is
rather similar to the 25 lg/kg in the present study. Additionally,
(A)
(B)
(C)
Figure 4 (A–C) Effects of BPA on (A) mean swim length (B) mean swim
speed and (C) mean latency to reach the platform in the Morris water maze,
in 4–6 months old male and female offspring exposed perinatally to BPA.
Mean values  SEM are shown, n = 18–22. Significant effects in low-dose
females compared to controls are indicated by * with p < 0.05. Significant
difference from 50 mg/kg females is indicated by # (p < 0.05). ¤ represents
a statistically significant difference from both the 5 and 50 mg/kg groups.
No statistically significant effect was seen in male offspring. For all three
endpoints, a significant difference between male and female performance
was seen in the control group, and in the groups exposed to 250 lg/kg and
50 mg/kg. This sex difference was not present in the animals from the
25 lg/kg and the 5 mg/kg groups. See text for more details on these sex
differences, including the respective p values.
Figure 5 Effect of BPA on sweetened water intake per 100 gram of body
weight in 6–7 months old female offspring exposed perinatally to BPA.
Group mean values  SEM are shown, n = 18–22. Intake of saccharin solu-
tion is significantly lower, indicated by * with p < 0.05 in the highest
exposed group compared to the control group. No effect of BPA exposure
was seen in the male offspring. In the control males the intake of sweetened
water was between 55 and 75 g per100 g bw, with SEM values between 4
and 7 (data not shown).
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a recent study has shown that pre- and postnatal exposure of SD
rats (n = 3) to 5 lg/kg bw/day of BPA also decreased epididymal
sperm count and motility at 70 days of age (Yang et al., 2015). In
that study no other doses of BPA were investigated.
Other studies have not found significant effects of low-dose
BPA on sperm count (Tinwell et al., 2002; Kato et al., 2006; How-
deshell et al., 2008; Delclos et al., 2014). In Kato et al. (2006),
neonatal male Sprague Dawley rats (N = 8) were given subcuta-
neous injections of BPA doses at 2, 11, 56, 277 and 97.000 lg/kg
bw/day from PND 0 to PND 9 and no effects of BPA on sperm
count was found. Tinwell et al. (2002) administered BPA (0.02,
0.1, 50 mg/kg bw/day) by oral gavage from GD 6 to 21 to two
strains of rat (Sprague Dawley and Alderley Park). In males at
PND 90, the highest BPA dose of 50 mg/kg induced significantly
reduced daily sperm production in the Alderly Park strain. How-
ever, at 20 lg/kg, the sperm production in the Alderly Park strain
appear around 7% lower than control values and the lack of sta-
tistical significance for this difference may be related to the lim-
ited group size of 7 litters per group. In Howdeshell et al. (2008),
Long-Evans hooded rats were gavaged with corn oil vehicle or
BPA (2, 20 and 200 lg/kg/day) during pregnancy through lacta-
tion from GD 7 to PND 18. A significantly increased incidence of
testicular degeneration was reported in the first block of the
study, but not in the second block of the study. When the
histopathology results from the two blocks were pooled, the total
incidence of testicular degeneration induced by BPA was not sta-
tistically different from controls. Treatment with BPA did not sig-
nificantly lower sperm counts at the doses used in this study.
However, the sperm counts generally appear around 5% lower
than control values at all doses and the lack of statistical signifi-
cance for these difference might be related to the limited num-
ber of exposed litters analysed in each of the four sub-blocks in
this study, that is N = 4–8. In Delclos et al. (2014), Sprague Daw-
ley rat dams were dosed by gavage from gestation day 6 until the
start of labour, and their pups were directly dosed from day 1
after birth to termination to seven equally spaced BPA doses
(2.5–2700 lg/kg bw/day) and two high BPA doses (100 000 and
300 000 lg/kg bw/day). No effect of BPA was reported on male
reproductive organ weights and sperm production. The Delcos
study included a sufficient number of males per group (18–23)
and a dose level similar to the dose where decrease in sperm
count was seen in the present study, that is 25 lg/kg. However,
the sperm count data are not shown in the Delclos paper and it
is therefore not possible for us to perform any further evalua-
tions of these data.
Overall, there is conflicting evidence with regard to low-dose
effects of BPA on sperm count. The unclear picture may to some
extent be due to the use of different dosing regimen, different rat
strains or species and especially the limited group sizes of 4–8 in
several studies.
The lowered sperm count observed in the present study was
not associated with changes in testis weight. It has been pro-
posed that perinatal exposure to estrogenic compounds may
alter Sertoli cell numbers (Atanassova et al., 2000, but this does
not seem to be the case for BPA in this study. Lower Sertoli cell
numbers would be expected to be associated with reduced tes-
tis weight, reduced seminiferous tubule diameter and possibly
altered timing of seminiferous tubule lumen formation, which
was not seen in the current study. Other causes of BPA-
induced effects on epididymal sperm counts may be
hypothesized, and further histological, immunohistochemical
and morphometrical analyses on testes as well as epididymides
may give further insight into possible causes of low sperm
counts. Occasional findings in a few testes from the low-dose
group could not be clearly associated with BPA exposure, but
call for further histological examination of testes from the other
dose groups.
Prostate development
Early exposure to weak and strong oestrogens can induce
adverse changes in prostate development. A recent study
revealed an increased incidence of multifocal inflammation and
reactive hyperplasia in Sprague Dawley rat ventral prostate at
6 months of age after prenatal exposure to 25 and 250 lg/kg
bw/day of BPA (Bernardo et al., 2015). In contrast to the current
study, BPA exposure induced increased ventral prostate weight,
increased proliferation of epithelial cells and changes in distri-
bution of compartments at PD 21 (Bernardo et al., 2015). It is
possible that different effects arise after pre- and postnatal expo-
sures, as no effects on inflammation in adult ventral prostate
were seen in the low-dose group of the current study, and as a
study on neonatal exposure to BPA revealed no pathological
changes at 6 months of age (Ho et al., 2006). However, a ‘second
hit’ of estradiol and testosterone in adult rats exposed neonatally
to BPA induced an increase in incidence of prostatic intraepithe-
lial neoplasia in ventral and dorsal prostate (Ho et al., 2006).
This indicates that more sensitive models using, for example,
hormone treatment may be necessary to detect effects of early
exposures on carcinogenesis. Chemically induced changes in
prostate development appears to be lobe specific (Prins et al.,
2011), and different results may be achieved by examination of
other prostate lobes or other BPA dose groups in the current
study.
Obesogenic effect
The body weight of the female offspring exposed to 25 lg/kg
was increased during the last part of our study, that is at 9–
14 months of age. A number of other studies in pre- and postna-
tally exposed rats and mice indicate that BPA exposure could
have an effect on metabolic function as evidenced by effects on
glucose or insulin regulation or lipogenesis, and body weight
gain (reviewed by EFSA 2015).
Rubin et al. (2001) have found increased body weights in male
and female offspring of Sprague Dawley female rats exposed via
drinking water to approximately 100 or 1200 lg BPA/kg bw/day
from GD 6 throughout the period of lactation. The increase per-
sisted longer in females than in males and on days 87 and 110
the low-dose BPA females showed higher body weights than
both control and high-dose females.
In the study of Somm et al. (2009) in rats receiving a dose of
approximately 70 lg/kg bw/day via drinking water from GD 6
until PND 21, body weight on PND 1 was increased in males and
females, whereas body weight was increased only in females
after weaning to 14 weeks of age.
Wei et al. (2011) administered doses of 0, 50, 250 or 1250 lg
BPA/kg bw/day orally by gavage in corn oil to pregnant Wistar
rats from GD 0 to PND 2. The offspring exposed prenatally to
50 lg BPA/kg bw/day showed increased weight gain from week
17 (females) or week 19 (males). No effects of BPA were observed
at doses of 250 or 1250 lg BPA/kg bw/day.
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In the study of Delclos et al. (2014), Sprague Dawley rats
were treated with BPA by oral gavage from gestation day 6
through the start of labour. BPA was then given directly to
pups from PND 1 until termination at PND 90  5 at doses
of 2.5, 8, 25, 80, 260, 840, 2 700, 100 000, and 300 000 lg/kg
bw/day. Reduced body weight was found on day 90 at the
dose of 300 mg/kg bw/day, whereas no signs of effect on
body weight were found in the adult offspring from the lower
dose groups.
In mice exposed to BPA in drinking water with doses corre-
sponding to 0, 260, 2720 lg/kg bw/day from GD 10 to PND 21,
body weights of female offspring were increased at both doses,
but for the males only at the high-dose group (Miyawaki et al.
2007).
Anderson et al. (2013) exposed mice 2 weeks before mating,
during gestation and lactation to BPA via the diet in doses cor-
responding to 0, 10.75 ng, 10.75 lg and 10.75 mg/kg bw/day.
One male and one female/litter were followed until 10 months
of age, and were given standard diet or diets containing BPA
at the same levels as administered to the dams. Body weight
and body fat was not statistically different from control in
either sex.
Overall, several studies indicate that especially low doses of
BPA, that is 50–260 lg/kg, can cause increased body weight in
rats and mice and that this effect in adulthood can be more per-
sistent or marked in females than in males. This picture is sup-
ported by the decreased body weight of the female offspring
exposed to 25 lg/kg at 9–14 months of age found in the present
study. There are, however, also studies where low doses of BPA
have not lead to increased body weight. The unclear picture may
to some extent be due to the use of different dosing regimen, dif-
ferent rat strains or species and especially that very few studies
have assessed body weight later in life, for example after
4 months of age.
Oestrus cycles
No significant effects on oestrus cyclicity were seen in the 1-
year-old BPA-exposed females, at any of the tested dose levels,
even though the percentage of regularly cycling females
seemed lower in the BPA-exposed animals. In a previous study
from our group, significantly lower proportion of regularly
cycling females was seen at 1 year of age after developmental
exposure to a mixture of 13 endocrine-disrupting chemicals
including BPA (Isling et al., 2014). This finding was interpreted
as a sign of premature reproductive senescence. The mixture
that affected oestrus cyclicity included a BPA dose of 675 lg/
kg bw/day. This is an intermediate dose compared to the BPA
doses used in the present study and where no effect was seen.
Thus, it seems that exposure to the other estrogenic and anti-
androgenic compounds included in the mixture probably
caused or contributed to the effect on oestrus cyclicity, result-
ing in a statistically significant effect in the mixture study, but
not in the present study on BPA alone. The mechanisms
behind the effects of endocrine disrupters on reproductive
ageing are still not well understood and generally effects on
reproductive ageing may be overlooked, since the evaluations
addressed in the current OECD test guidelines for reproductive
toxicology testing are focused on effects in young adult ani-
mals and do not include investigations of effects in old age
after developmental exposure.
Anxiety behaviour
No significant effects of the BPA exposure were seen on motor
activity or anxiety behaviour in the elevated plus maze (EPM), in
either males or females. The lack of effect on motor activity in
this study is in accordance with other data showing no effect on
motor activity in BPA-exposed offspring (e.g. Stump et al., 2010;
Kuwahara et al., 2013). A number of studies have reported
effects of developmental exposure to BPA on anxiety-like beha-
viours in EPM in rodents (e.g. Jones & Watson, 2012; Patisaul
et al., 2012; Gioiosa et al., 2013). Both increases and decreases in
anxiety levels have been reported in these studies, however they
consistently report that BPA-exposed adult offspring showed dis-
appearance of the normal sexual dimorphism in exploratory
behaviour in the EMP. A new study conducted as part of the
CLARITY-BPA (Consortium Linking Academic and Regulatory
Insights on BPA Toxicity) programme do not indicate BPA-
related effects on anxiety or exploratory activity using assess-
ment in open field, EMP and zero maze (Rebuli et al., 2015).
However, similarly as in the present study, the expected sex dif-
ferences in EPM performance were not consistently observed in
the control groups, and thus considered a potential limitation of
both studies.
Spatial learning and memory
The spatial learning in Morris water maze was affected in the
female offspring as females from the lowest dose group (25 lg/
kg bw/day) showed significantly decreased swim length and
swim speed. Also, the females showed male-like performance as
the normal sexual dimorphism seen on the control group was
not observed in the BPA-exposed animals.
Several animal studies have reported that developmental
exposure to BPA can interfere with learning and memory capaci-
ties in different learning tasks in rodents, including spatial learn-
ing, passive avoidance learning and object recognition (for
review, see EFSA 2015). Some studies report significant impair-
ment of either learning and/or memory capacities (both in spa-
tial and non-spatial learning tasks), whereas other do not.
Studies of effects of low doses of BPA on spatial learning in
Morris water maze or other spatial learning mazes show conflict-
ing results. In Xu et al. (2010) male ICR mice were perinatally
exposed to BPA (0.05, 0.5, 5 and 50 mg/kg bw) and tested as
weanlings and as adults in the Morris water maze. Increased
swim lengths were seen for the upper two doses in weanlings
and the upper three doses in adult males. In another study from
the same group (Xu et al., 2011a), control females showed longer
swim length to the hidden platform (i.e. slower learners) than
control males. The lowest BPA dose (40 lg/kg/day) caused
increased swim length in males, whereas no effects were seen in
females at any of the tested dose levels (i.e. 40 and 400 lg/kg/
day). Thus, the sex differences in spatial learning and memory
were abolished at 40 lg/kg/day. Jasarevic et al. (2013) reported
that male but not female deer mice (n = 6–10) orally exposed
during pre- and postnatal development to BPA (0.05, 5 or
50 mg/kg feed, equivalent to 0.25, 25 or 250 lg/kg bw/day) had
impaired learning performance in the Barnes maze at 25 and
250 lg/kg bw/day. Also, the typical sex differences in spatial
learning, of adult deer mice were diminished following develop-
mental exposure to BPA. In Ferguson et al. (2012), low doses of
BPA (2.5 or 25 lg/kg bw/day) given to Sprague Dawley dams
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(n = 11–12) by oral gavage on gestational days 6–21 and then to
the offspring from birth to weaning, did not show any significant
effects on spatial learning in adolescent/adult offspring neither
in the Barnes maze nor in the Morris water maze. Jones & Wat-
son (2012) used the Morris water maze and found no spatial
learning effects in adult offspring (PND 90–150) of Long-Evans
rat dams orally exposed to BPA (5, 50, 500, or 5000 lg/kg bw/
day) during gestation and lactation. However, the number of off-
spring studied was very limited as the study only included 2–3
litters per group. Also, Viberg et al. (2011) found no effect on
learning and memory in the Morris water maze in 6-month-old
mice orally exposed neonatally to single doses of BPA (0, 0.32,
3.2 or 4.8 mg/kg bw). The group study included 3–4 litters per
group.
Kuwahara et al. (2013) assessed spatial learning in male Spra-
gue Dawley rats orally administered BPA (50 or 500 lg/kg/day)
from GD 10 to PND 14. In an appetite-motivated maze test male
offspring exposed to 50 lg/kg used significantly more time to
reach the reward, whereas no significant differences were seen
in the Morris water maze test. The number of males tested per
group was 12, but the number of litters per group was not stated.
The unclear picture for effects of BPA on spatial learning may
to some extent be due to the use of different exposure regimen,
different species (mice and rats) or age, and different strains as
well as different dose levels of BPA in the studies. The choice of
dose levels may be especially important, as the present study
indicates that the effect of BPA on female spatial learning is non-
monotonic. Also, only some of the studies have included focus
on gender-related effect on the normal sexual dimorphism in
spatial learning. Last but not the least, the unclear picture may
also be due to underpowered sample size, that is the use of small
group sizes of 2–6 in most of these studies. This is in contrast to
the present study where a group size of 18–20 was used.
In Johnson et al. (2015), three doses of BPA (2.5, 25 and
2500 lg/kg bw/day) or a 0.5 lg/kg/day ethinyl estradiol dose
were given to Sprague Dawley dams (as part of the CLARITY-
BPA programme mentioned above). Dams were dosed by oral
gavage on gestational days 6–21, whereas offspring were dosed
directly from birth to weaning. The study examines effect of
perinatal BPA exposure in a Barnes Maze and found that the
2500 BPA, and to a lesser extent the 2.5 BPA dose, prolonged
latency in females, and the lowest dose (2.5 lg/kg bw/day)
improved responses (shorter latency) in males. These findings
indicate that developmental exposure to BPA can disrupt aspects
of spatial navigational learning and memory in a sex-dependent
manner. The developmental neurotoxicity study from Stump
et al. (2010) have used group sizes similar those in the present
study and examined spatial learning and memory in the Biel
Maze test. BPA was offered to female Crl:CD(SD) rats (24 per
dose group) and their litters at dietary concentrations of 0 (con-
trol), 0.15, 1.5, 75, 750, and 2250 ppm daily from GD 0 through
PND 21. The females in the 0.15 and 2250 ppm feed groups
showed significantly improved performance (i.e. they made
fewer errors than the controls) at PND 22 in Path B (trials 5–10).
The 0.15 ppm in feed equals a dose of 10–30 lg/kg bw/day
which is dose very similar to the dose of 25 lg/kg bw/day, where
the present study have also found improved spatial learning in
female offspring. Also, at PND 62 the male offspring from the
0.15 ppm feed exposure group showed impaired learning
manifested as a significant increase in the overall mean number
of errors. The conclusion in Stump et al. (2010) is that there were
no effects of BPA on spatial learning. The argument given is that
the statistically significant differences noted were considered
spurious and not BPA related because they did not occur consis-
tently between or within testing periods and did not demon-
strate any evidence of a dose-related trend. However, we find
that lack of consistency within and between tasting periods is
not a valid argument for dismissing significant effects on learn-
ing, as learning is an ongoing process and, for example initial
learning can only be assessed once. Also, we find that the lack of
dose-related trend is an insufficient argument for dismissing sig-
nificant effect as several studies have shown non-monotonic
dose–response for some effects of BPA and other endocrine dis-
rupting substances. We therefore find that the significant effect
on female spatial learning at 10–30 lg/kg bw/day in the Stump
study strongly supports the very similar effect on female spatial
learning at 25 lg/kg bw/day in the present study.
Sweet preference
In the sweet preference test, no effects were seen in the male
offspring. However, the female preference for sweetened water
decreased with increasing BPA exposure, and the females in the
highest exposed group (50 mg BPA/kg bw/day) had significantly
lower intake compared to the control group, that is these female
showed signs of masculinized or defeminized behaviour. These
results appear different from the findings by Xu et al. (2011b),
where Sprague Dawley rats were perinatally exposed to BPA
doses of 0.01, 0.1 or 1.0 mg/L in drinking water from GD 11 to
PND 21. The male rats in the two highest dose groups increased
their intake of the saccharin solution compared to the controls,
whereas the females were unaffected by exposure. However, the
paper does not report the dose levels calculated into mg/kg bw/
day and there were only 6–8 animals per group which compli-
cates the comparison to the present findings. Sweet preference
has also been investigated in female Long-Evans rat offspring
exposed to EE2 (0.05–50 lg/kg/day) or low doses of BPA (2, 20
and 200 lg/kg/day) from GD 7 to PD 18 (Ryan et al., 2010). A
statistically significant difference between male and female con-
trol rats was observed, but offspring exposed to BPA were unaf-
fected. This does not contradict the present finding as the effect
in the present study was found at a much higher dose of BPA.
Interestingly the sweet preference test conducted with offspring
exposed to EE2 showed reduced saccharin solution intake in
females, indicating that another estrogenic chemical masculin-
ized the behaviour of the female rat (Ryan et al., 2010). Overall,
the significant effect on female sweet preference observed in the
present study after high-dose BPA exposure indicates that BPA
may interact with the sexually dimorphic development of the
brain leading to masculinized or defeminized behaviour of the
female offspring.
Monotonic vs. non-monotonic dose–response relationships
The present study has found several statistically significant
adverse effects only at the lowest tested dose of BPA (25 lg/
kg bw/day). These include decreased sperm count, effect on
spatial learning in adult female offspring and increased body
weight late in female life as well as altered mammary gland
development in 22-day-old males (Mandrup et al., 2016). Seen
© 2016 American Society of Andrology and European Academy of Andrology Andrology, 2016, 4, 594–607 603
DEVELOPMENTAL BISPHENOL A EXPOSURE IN RATS ANDROLOGY
separately, these findings indicating non-monotonic dose–
response relationship could be interpreted as random
findings. However, the fact that several endpoints were only
significantly affected at this low dose indicates that these
effects were not random findings, and that some aspects of
sexual- and neurobehavioural differentiation were affected
only after exposure to this low dose of BPA.
Statistical analysis can aid to elucidate whether the low-dose
effects found in the present study and other studies represent
‘real’ non-monotonic dose–response relationships, that is the
effects in the low-dose group were both significantly different
from controls and from the other higher exposure groups. For
the observed effects on both sperm count and female spatial
learning at 25 lg/kg this appeared to be the case as the results at
25 lg/kg were also significantly different from the results in the
highest BPA dose groups, that is 5 and 50 mg/kg. Thus, for these
endpoints the exposure to BPA during development does seem
to result in non-monotonic dose–response relationships in the
lg/kg dose span.
The present study also showed that some other endocrine sen-
sitive endpoints were not affected (e.g. almost all of the investi-
gated reproductive organs) or were affected showing a
monotonic dose–response relationship (e.g. sweet preference in
the present paper as well as male and female anogenital and dis-
tance nipple retention in Christiansen et al., 2014). That differ-
ent endpoints within the same study can be affected in different
ways, for example show monotonic or non-monotonic relation-
ships, is important to keep in mind when evaluating effects of
endocrine disrupters.
Mode of action
The mode of action of BPA leading to the effects in this study
is not clarified and may involve several differential modes of
actions. In the ToxCastTM programme, launched by US-EPA to
develop ways to predict potential toxicity of chemicals and to
develop a cost-effective approach for prioritizing the thousands
of chemicals that need toxicity testing, BPA was shown to have
an effect in 101 out of 467 in vitro toxicity assays (Reif et al.,
2010). Thus, BPA’s toxicological effects are not limited to the
classical oestrogenic mechanism (Shelby, 2008) and comprise
several other signalling pathways. In addition to being an ER
agonist, BPA also shows activity on the androgen receptor (AR),
other nuclear receptors, and xenobiotic metabolizing enzymes
(including aromatase) (Reif et al., 2010). In the literature, BPA
has shown estrogenic properties, the ability to antagonize AR
activation with an IC50 in the micromolar range (Paris et al.,
2002; Bonefeld-Jorgensen et al., 2007) and the ability to inhibit
aromatase (Bonefeld-Jorgensen et al., 2007). In addition, BPA
has been found to inhibit testosterone production and E2 meta-
bolism in H295R cells (Zhang et al., 2011). Moreover, a study by
Maamar et al. (2015) investigated possible direct endocrine dis-
ruption by BPA of the foetal testes of two rat strains (14.5–
17.5 days post-coitum) and humans (8–12 gestational weeks)
under different culture conditions. The authors reported that
BPA can display anti-androgenic effects both in rat and human
foetal testes (Maamar et al., 2015).
Consequently, interpretation of BPA effects only in terms of an
oestrogen-mimicking effect would be far too simplistic. The
involvement of several of these mechanisms could explain the
non-monotonic dose–response relationship seen in this study
and other studies at low doses of BPA. It has for example been
suggested that at low doses, BPA almost exclusively binds to the
oestrogen receptor, but at high doses, it can also bind weakly to
other hormone receptors such as the androgen receptor and thy-
roid hormone receptor (Vandenberg et al., 2012). This property
of BPA might contribute to the non-monotonic dose–response
observed in our study.
CONCLUSION
In conclusion, the present results show that exposure to a low
dose of BPA (25 lg/kg bw/day) during development may cause
adverse effects on male reproductive development leading to
decreased sperm count, affect sexually dimorphic development
of the brain leading to masculinization of spatial learning in
female offspring and lead to increase female body weights late in
life. The results indicate non-monotonic dose–response relation-
ships for these effects.
These new results do not change the lowest observed effect
level (LOAEL) in our BPA study, as anogenital distance in new
born females (reported in Christiansen et al., 2014) and male
mammary gland differentiation on PD 22 (Mandrup et al.,
2016) were also significantly affected at the 25 lg/kg bw/day.
However, the severity of the adverse effects observed in the
adult offspring adds further to the concern for effects of low
doses of BPA. The multitude of adverse effects observed at
25 lg/kg bw/day in rats suggest that the new temporary TDI
of 4 lg/kg bw/day proposed by EFSA is not sufficiently pro-
tective with regard to endocrine disrupting effects of BPA in
humans.
The aggregated exposure to BPA for highly exposed humans
are according to the recent exposure assessment from EFSA 1.01
to 1.06 lg/kg bw/day for men and women and 1.26 to 1.45 lg/
kg bw/day for children (3–10 years) and teenagers (EFSA 2015).
These exposure levels are only somewhat lower than the 25 lg/
kg that caused adverse effects in rats in the present study as well
as in other studies. This indicates that highly exposed humans
may not be sufficiently protected with regard to endocrine dis-
rupting effects of BPA.
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MEETING COMMENTS*
Monica Lind (Uppsala, Sweden)
We are performing low-dose BPA studies at Uppsala indepen-
dent of the CLARITY-BPA study described by Jerry Heindel at
this Workshop. We use Fischer strain rats, you use Wistar rats,
and Sprague–Dawley rats are used in CLARITY. The different
strains of rat have marked differences in their response to BPA
and I would like to know why laboratories choose to use a speci-
fic strain. Your studies on sperm count show results different
from other laboratories and this might also be explained by
strain differences.
Ulla Hass (Søborg, Denmark)
Strain is probably relevant to sperm counts after exposure to
BPA. I think CD rats and Long–Evans rats were used in other lab-
oratories. I do not know why Sprague–Dawley rats were selected
for CLARITY.
Richard Sharpe (Edinburgh, UK)
Your study is impressive and the design is excellent. You sug-
gested that BPA is possibly exerting an oestrogenic effect on your
rats because of the behavioural changes observed. The exact
mechanism of action is not known. It might be possible to deter-
mine if the effects are genomic ER-mediated by using low-dose
BPA +/ an ER antagonist. However, an antagonist might be too
much of a confounder.
Ulla Hass
In the first instance, we could see if treatment with oestrogen
itself has the same effect on spatial learning as BPA. We would
also have to look at the effect of the ER antagonist on its own to
check for toxicity and its effect on the pups. BPA might also be
acting directly as oestrogen during brain development but not
acting through ER, for example, it might cause an increase in ER
receptor numbers in the brain. There are other effects of oestro-
gen whose mode of action is not ER agonism. Your suggestion is
valid and should be investigated.
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